New rule delays MCIT ‘breakthrough technology’ effective date
The effect of a last-minute Trump administration rule empowering more and speedier medical device authorization has been delayed by the Biden administration pending collection and analysis of new stakeholder comments.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.